This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: National Institute of Health and Medical Research, Université Paris Descartes, Centre National De La Recherche Scientifique. Active years: 2019-2021.
Company Filing History:
2 out of 1,853 
2 out of 132 
1 out of 5,383 
Years Active: 2019-2021
Title: Slobodan Culina: Innovator in Diabetes Treatment
Introduction
Slobodan Culina is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of diabetes. With a total of 2 patents, his work focuses on innovative approaches to immune tolerance and T-cell receptors.
Latest Patents
Culina's latest patents include groundbreaking inventions that address critical health issues. The first patent involves T-cell receptors (TCR) that recognize pancreatic beta-cell epitopes, which are essential for the diagnosis and treatment of diabetes. This invention aims to enhance the understanding and management of diabetes through targeted therapies. The second patent presents methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with Fc-coupled antigens. This method offers a novel approach to inducing tolerance to specific antigens, potentially improving treatment outcomes for patients.
Career Highlights
Throughout his career, Slobodan Culina has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris Descartes. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Culina has collaborated with notable colleagues, including Roberto Mallone and Georgia Afonso. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Slobodan Culina's contributions to the field of diabetes treatment through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches have the potential to significantly impact patient care and treatment strategies.